Literature DB >> 16956880

Proteolytic cleavage and nuclear translocation of fibrocystin is regulated by intracellular Ca2+ and activation of protein kinase C.

Thomas Hiesberger1, Eric Gourley, Andrea Erickson, Peter Koulen, Christopher J Ward, Tatyana V Masyuk, Nicholas F Larusso, Peter C Harris, Peter Igarashi.   

Abstract

Fibrocystin, a type I membrane protein of unknown function, is the protein affected in the autosomal recessive form of polycystic kidney disease. Here we show that fibrocystin undergoes regulated proteolysis. Several proteolytic cleavages occur within the predicted ectodomain, whereas at least one cleavage occurs within the cytoplasmic portion. The latter generates a C-terminal intracellular fragment that harbors the nuclear localization signal KRKVSRLAVTGERTATPAPKIPRIT and translocates to the nucleus. Proteolytic cleavage of fibrocystin occurs constitutively in long term cultures of polarized inner medullary collecting duct cells (mIMCD-3). Activation of protein kinase C and release of intracellular Ca2+ are required for proteolysis under these conditions. In short term cultures of human embryonic kidney 293 cells (HEK-293), proteolytic cleavage of fibrocystin can be elicited by stimulation of intracellular Ca2+ release or activation of protein kinase C. These results identify a novel Ca2+-dependent pathway that signals from fibrocystin located in the cell membrane to the nucleus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16956880     DOI: 10.1074/jbc.M606740200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

Review 1.  Polycystic liver diseases: congenital disorders of cholangiocyte signaling.

Authors:  Mario Strazzabosco; Stefan Somlo
Journal:  Gastroenterology       Date:  2011-04-22       Impact factor: 22.682

2.  Tagged fibrocystin sheds its secrets.

Authors:  Vishal Patel
Journal:  J Am Soc Nephrol       Date:  2011-11-11       Impact factor: 10.121

3.  Uromodulin is expressed in renal primary cilia and UMOD mutations result in decreased ciliary uromodulin expression.

Authors:  Frank Zaucke; Joana M Boehnlein; Sarah Steffens; Roman S Polishchuk; Luca Rampoldi; Andreas Fischer; Andreas Pasch; Christoph W A Boehm; Anne Baasner; Massimo Attanasio; Bernd Hoppe; Helmut Hopfer; Bodo B Beck; John A Sayer; Friedhelm Hildebrandt; Matthias T F Wolf
Journal:  Hum Mol Genet       Date:  2010-02-18       Impact factor: 6.150

Review 4.  Substrate specificity of gamma-secretase and other intramembrane proteases.

Authors:  A J Beel; C R Sanders
Journal:  Cell Mol Life Sci       Date:  2008-05       Impact factor: 9.261

Review 5.  Ciliary dysfunction in polycystic kidney disease: an emerging model with polarizing potential.

Authors:  Robert J Kolb; Surya M Nauli
Journal:  Front Biosci       Date:  2008-05-01

6.  A novel model of autosomal recessive polycystic kidney questions the role of the fibrocystin C-terminus in disease mechanism.

Authors:  Patricia Outeda; Luis Menezes; Erum A Hartung; Stacey Bridges; Fang Zhou; Xianjun Zhu; Hangxue Xu; Qiong Huang; Qin Yao; Feng Qian; Gregory G Germino; Terry Watnick
Journal:  Kidney Int       Date:  2017-07-18       Impact factor: 10.612

7.  Polyductin undergoes notch-like processing and regulated release from primary cilia.

Authors:  Jun-ya Kaimori; Yasuyuki Nagasawa; Luis F Menezes; Miguel A Garcia-Gonzalez; Jie Deng; Enyu Imai; Luiz F Onuchic; Lisa M Guay-Woodford; Gregory G Germino
Journal:  Hum Mol Genet       Date:  2007-04-15       Impact factor: 6.150

Review 8.  Trafficking of receptor tyrosine kinases to the nucleus.

Authors:  Graham Carpenter; Hong-Jun Liao
Journal:  Exp Cell Res       Date:  2008-10-11       Impact factor: 3.905

9.  Kidney cysts, pancreatic cysts, and biliary disease in a mouse model of autosomal recessive polycystic kidney disease.

Authors:  Scott S Williams; Patricia Cobo-Stark; Leighton R James; Stefan Somlo; Peter Igarashi
Journal:  Pediatr Nephrol       Date:  2008-02-20       Impact factor: 3.714

Review 10.  Polycystic kidney diseases: from molecular discoveries to targeted therapeutic strategies.

Authors:  O Ibraghimov-Beskrovnaya; N Bukanov
Journal:  Cell Mol Life Sci       Date:  2008-02       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.